(lp0
S'Anika Therapeutics, Inc.  Buckles Under The Trend Lines Midway Monitor - 10 hours ago We see here that Anika Therapeutics, Inc.  is -7.06% away from the 20-Day Simple Moving Average. Their 50-Day Simple Moving Average is a difference of -12.82% from current levels.'
p1
aS'Why Anika Therapeutics Inc. Shares Skyrocketed Motley Fool - Feb 26, 2014 What: Shares of Anika Therapeutics , a biopharmaceutical company focused on developing therapies for tissue protection, healing, and repair, jumped as much as 52% after the Food and Drug Administration gave marketing approval for the&nbsp;..., A New Single Injection Treatment for Treatment of Pain Due to Osteoarthritis ... - Business Wire What does the approval of Monovisc mean for Anika Therapeutics? - Boston Business Journal '
p2
aS'Anika Therapeutics, Inc. Announces First Patient Enrolled in FastTRACK Phase ... Business Wire  - Dec 29, 2015 BEDFORD, Mass.----Anika Therapeutics, Inc., , a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced the enrollment of the&nbsp;...'
p3
aS'Why Anika Therapeutics Gained 13% in July Motley Fool - Aug 7, 2015 Anika pleased investors during the month by reporting second-quarter earnings of $0.51 per-share, which was well ahead of the $0.34 that analysts were expecting.'
p4
aS"Anika Therapeutics, Inc Surges On Approval, but Is It Overpriced Now? Motley Fool - Mar 3, 2014 Anika  jumped by a third following the FDA's approval of Monovisc, its single injection treatment for osteoarthritis knee pain."
p5
aS'The Anika Therapeutics Inc  Stake Held by Public Sector Pension ... Petro Global News 24 - Mar 20, 2017 Public Sector Pension Investment Board maintained its position in Anika Therapeutics Inc  during the fourth quarter, Holdings Channel reports.AQR Capital Management LLC Has $5566000 Position in Anika Therapeutics Inc  - Sports Perspectives'
p6
aS'-T To Relieve Pain and Restore Function of Tendons Damaged by Chronic Injury Business Wire  - Dec 19, 2016 BEDFORD, Mass.----Anika Therapeutics, Inc., , a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid HA technology, today announced that it received CE&nbsp;...'
p7
aS'Anika Therapeutics Inc.  Moves Lower on Volume Spike for February 22 Equities.com - Feb 22, 2017 Anika Therapeutics Inc.  traded on unusually high volume on Feb. 22, as the stock lost 0.22% to close at $49.09. On the day, Anika Therapeutics Inc. saw 162,848 shares trade hands on 1,447 trades. Considering that the stock averages only a daily&nbsp;...Zacks Investment Research Upgrades Anika Therapeutics Inc.  to Buy - Chaffey Breeze'
p8
aS'Anika Therapeutics Wins CE Mark Approval for Cingal Business Wire  - Mar 28, 2016 BEDFORD, Mass.----Anika Therapeutics, Inc., , a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid HA technology, today announced that it received&nbsp;...'
p9
aS'Anika Therapeutics Delivers Solid Second Quarter 2015 Financial Results and ... Business Wire  - Jul 29, 2015 BEDFORD, Mass.----Anika Therapeutics, Inc. , a leader in products for tissue protection, healing, and repair based on hyaluronic acid  technology, today reported financial results for the second quarter ended June 30,&nbsp;...'
p10
a.